These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21108824)

  • 1. Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design.
    Menchetti M; Bortolotti B; Rucci P; Scocco P; Bombi A; Berardi D;
    BMC Psychiatry; 2010 Nov; 10():97. PubMed ID: 21108824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moderators of remission with interpersonal counselling or drug treatment in primary care patients with depression: randomised controlled trial.
    Menchetti M; Rucci P; Bortolotti B; Bombi A; Scocco P; Kraemer HC; Berardi D;
    Br J Psychiatry; 2014 Feb; 204(2):144-50. PubMed ID: 24311553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating Depression: What Patients Want; Findings From a Randomized Controlled Trial in Primary Care.
    Magnani M; Sasdelli A; Bellino S; Bellomo A; Carpiniello B; Politi P; Menchetti M; Berardi D
    Psychosomatics; 2016; 57(6):616-623. PubMed ID: 27393388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of brief interpersonal psychotherapy for depression among women.
    Swartz HA; Frank E; Shear MK; Thase ME; Fleming MA; Scott J
    Psychiatr Serv; 2004 Apr; 55(4):448-50. PubMed ID: 15067162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term psychodynamic psychotherapy and fluoxetine in major depressive disorder: a randomized comparative study.
    Salminen JK; Karlsson H; Hietala J; Kajander J; Aalto S; Markkula J; Rasi-Hakala H; Toikka T
    Psychother Psychosom; 2008; 77(6):351-7. PubMed ID: 18701831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care: the THREAD (THREshold for AntiDepressant response) study.
    Kendrick T; Chatwin J; Dowrick C; Tylee A; Morriss R; Peveler R; Leese M; McCrone P; Harris T; Moore M; Byng R; Brown G; Barthel S; Mander H; Ring A; Kelly V; Wallace V; Gabbay M; Craig T; Mann A
    Health Technol Assess; 2009 Apr; 13(22):iii-iv, ix-xi, 1-159. PubMed ID: 19401066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.
    Lespérance F; Frasure-Smith N; Koszycki D; Laliberté MA; van Zyl LT; Baker B; Swenson JR; Ghatavi K; Abramson BL; Dorian P; Guertin MC;
    JAMA; 2007 Jan; 297(4):367-79. PubMed ID: 17244833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined brief dynamic therapy and pharmacotherapy in the treatment of major depressive disorder: a pilot study.
    Maina G; Rosso G; Crespi C; Bogetto F
    Psychother Psychosom; 2007; 76(5):298-305. PubMed ID: 17700050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy of major depression with concomitant borderline personality disorder: comparison of interpersonal and cognitive psychotherapy.
    Bellino S; Zizza M; Rinaldi C; Bogetto F
    Can J Psychiatry; 2007 Nov; 52(11):718-25. PubMed ID: 18399039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Task shifting interpersonal counseling for depression: a pragmatic randomized controlled trial in primary care.
    Matsuzaka CT; Wainberg M; Norcini Pala A; Hoffmann EV; Coimbra BM; Braga RF; Sweetland AC; Mello MF
    BMC Psychiatry; 2017 Jun; 17(1):225. PubMed ID: 28637449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: a subgroup analysis and Montgomery-Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study.
    Ozaki N; Otsubo T; Kato M; Higuchi T; Ono H; Kamijima K;
    Psychiatry Clin Neurosci; 2015 Jan; 69(1):34-42. PubMed ID: 24965202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geriatric depression treatment in nonresponders to selective serotonin reuptake inhibitors.
    Whyte EM; Basinski J; Farhi P; Dew MA; Begley A; Mulsant BH; Reynolds CF
    J Clin Psychiatry; 2004 Dec; 65(12):1634-41. PubMed ID: 15641868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder.
    Khan A; Cutler AJ; Kajdasz DK; Gallipoli S; Athanasiou M; Robinson DS; Whalen H; Reed CR
    J Clin Psychiatry; 2011 Apr; 72(4):441-7. PubMed ID: 21527122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.
    Ishak WW; Christensen S; Sayer G; Ha K; Li N; Miller J; Nguyen JM; Cohen RM
    J Clin Psychiatry; 2013 Mar; 74(3):256-61. PubMed ID: 23561231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, randomized, placebo-controlled trial of augmentation with lamotrigine or placebo in patients concomitantly treated with fluoxetine for resistant major depressive episodes.
    Barbosa L; Berk M; Vorster M
    J Clin Psychiatry; 2003 Apr; 64(4):403-7. PubMed ID: 12716240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for child and adolescent depression in primary care settings: a systematic evidence review for the US Preventive Services Task Force.
    Williams SB; O'Connor EA; Eder M; Whitlock EP
    Pediatrics; 2009 Apr; 123(4):e716-35. PubMed ID: 19336361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.